Back

Pathogenic strains of a gut commensal drive systemic platelet activation and thromboinflammation in lupus nephritis

Amarnani, A.; Rivera, C. F.; Cornwell, M.; Weinstein, T.; Gottesman, S.; Loomis, C.; Azad, Z.; Lee, A.; Prasad, J.; Barnes, B. J.; Yi, M.; Ullah, N.; Gisch, N.; Ruggles, K.; Ramkhelawon, B.; Silverman, G. J.

2025-06-24 immunology
10.1101/2025.06.20.641288 bioRxiv
Show abstract

Imbalances in the gut microbiome have been linked to increased intestinal permeability and disease flares in systemic lupus erythematosus (SLE). Our study revealed that patients with flares of lupus nephritis (LN) and intestinal expansions of the anaerobic commensal, Ruminococcus gnavus (RG), displayed whole blood transcriptome profiles indicative of platelet, neutrophil, and myeloid cell activation, a profile reminiscent of sepsis. Serum analysis confirmed elevated serum levels of Platelet Factor 4 and neutrophil extracellular traps, which significantly correlated with levels of IgG-antibody to a novel lipoglycan (LG) produced by pathogenic RG strains, which was also documented in an independent LN cohort. To test for causality, in vivo mouse models further demonstrated that gut colonization with LG-producing RG strains, as well as a single intraperitoneal challenge with an LG preparation, caused platelet activation and megakaryocytosis in bone marrow and spleen. Mice colonized with RG strains that produce LG developed cellular infiltration of the kidneys by neutrophils and monocytes. Hence, RG expansions during renal flares may identify a specific LN flare endotype driven by thromboinflammatory mechanisms. Antibodies that arise from immune exposure to the RG lipoglycan may serve as a surrogate biomarker, helping to elucidate the impact of the relationship between gut microbiota communities and clinical outcomes in patients afflicted by LN. [208] Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=164 SRC="FIGDIR/small/641288v1_ufig1.gif" ALT="Figure 1"> View larger version (74K): org.highwire.dtl.DTLVardef@1239f8eorg.highwire.dtl.DTLVardef@1c062caorg.highwire.dtl.DTLVardef@195ece2org.highwire.dtl.DTLVardef@1f3123f_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Clinical Immunology
21 papers in training set
Top 0.1%
15.2%
2
Frontiers in Immunology
586 papers in training set
Top 0.3%
13.1%
3
JCI Insight
241 papers in training set
Top 0.4%
6.5%
4
Arthritis & Rheumatology
33 papers in training set
Top 0.1%
5.0%
5
eLife
5422 papers in training set
Top 24%
3.7%
6
Brain, Behavior, and Immunity
105 papers in training set
Top 0.6%
3.7%
7
Immunology
29 papers in training set
Top 0.3%
2.2%
8
Frontiers in Genetics
197 papers in training set
Top 4%
2.0%
50% of probability mass above
9
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.4%
1.8%
10
Cell Reports Medicine
140 papers in training set
Top 3%
1.8%
11
Cell Reports
1338 papers in training set
Top 23%
1.7%
12
Computational and Structural Biotechnology Journal
216 papers in training set
Top 5%
1.5%
13
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.4%
14
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 4%
1.3%
15
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.5%
1.1%
16
Rheumatology
21 papers in training set
Top 0.3%
1.1%
17
EMBO Molecular Medicine
85 papers in training set
Top 3%
1.0%
18
Vaccines
196 papers in training set
Top 2%
1.0%
19
The Journal of Immunology
146 papers in training set
Top 1%
0.8%
20
Journal of Experimental Medicine
106 papers in training set
Top 3%
0.8%
21
mBio
750 papers in training set
Top 10%
0.8%
22
Nature Communications
4913 papers in training set
Top 62%
0.8%
23
Arthritis Research & Therapy
15 papers in training set
Top 0.3%
0.8%
24
iScience
1063 papers in training set
Top 30%
0.8%
25
Scientific Reports
3102 papers in training set
Top 75%
0.7%
26
Microbiology Spectrum
435 papers in training set
Top 5%
0.7%
27
Journal of Advanced Research
15 papers in training set
Top 0.8%
0.7%
28
Advanced Science
249 papers in training set
Top 19%
0.7%
29
mSystems
361 papers in training set
Top 8%
0.7%
30
eBioMedicine
130 papers in training set
Top 5%
0.7%